If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Moira Marizzoni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences
Disease Progression Medicine & Life Sciences
Healthy Volunteers Medicine & Life Sciences
Gyrus Cinguli Medicine & Life Sciences
Diffusion Tensor Imaging Medicine & Life Sciences
Brain Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 518 Citations
  • 14 h-Index
  • 35 Article
  • 2 Review article

Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases

Babiloni, C., Del Percio, C., Pascarelli, M. T., Lizio, R., Noce, G., Lopez, S., Rizzo, M., Ferri, R., Soricelli, A., Nobili, F., Arnaldi, D., Famà, F., Orzi, F., Buttinelli, C., Giubilei, F., Salvetti, M., Cipollini, V., Franciotti, R., Onofrj, M., Stirpe, P. & 22 others, Fuhr, P., Gschwandtner, U., Ransmayr, G., Aarsland, D., Parnetti, L., Farotti, L., Marizzoni, M., D'Antonio, F., De Lena, C., Güntekin, B., Hanoğlu, L., Yener, G., Emek-Savaş, D. D., Triggiani, A. I., Taylor, J. P., McKeith, I., Stocchi, F., Vacca, L., Hampel, H., Frisoni, G. B., De Pandis, M. F. & Bonanni, L., May 1 2019, In : Neurobiology of Aging. 77, p. 112-127 16 p.

Research output: Contribution to journalArticle

Alpha Rhythm
Lewy Body Disease
Prodromal Symptoms
Lewy Bodies
Dementia

Biomarker matrix to track short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer's disease

Marizzoni, M., Ferrari, C., Macis, A., Jovicich, J., Albani, D., Babiloni, C., Cavaliere, L., Didic, M., Forloni, G., Galluzzi, S., Hoffmann, K. T., Molinuevo, J. L., Nobili, F., Parnetti, L., Payoux, P., Pizzini, F., Rossini, P. M., Salvatore, M., Schönknecht, P., Soricelli, A. & 10 others, Del Percio, C., Hensch, T., Hegerl, U., Tsolaki, M., Visser, P. J., Wiltfang, J., Richardson, J. C., Bordet, R., Blin, O. & Frisoni, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

Sample Size
Cerebrospinal Fluid
Disease Progression
Parahippocampal Gyrus
Alzheimer Disease
3 Citations (Scopus)

Plasma Aβ 42 as a biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: Evidence from the PharmaCog/E-ADNI Study

Albani, D., Marizzoni, M., Ferrari, C., Fusco, F., Boeri, L., Raimondi, I., Jovicich, J., Babiloni, C., Soricelli, A., Lizio, R., Galluzzi, S., Cavaliere, L., Didic, M., Schönknecht, P., Molinuevo, J. L., Nobili, F., Parnetti, L., Payoux, P., Bocchio, L., Salvatore, M. & 9 others, Rossini, P. M., Tsolaki, M., Visser, P. J., Richardson, J. C., Wiltfang, J., Bordet, R., Blin, O., Forloni, G. & Frisoni, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 37-48 12 p.

Research output: Contribution to journalArticle

Open Access
Clusterin
Disease Progression
Alzheimer Disease
Biomarkers
Prodromal Symptoms
1 Citation (Scopus)

Predicting and tracking short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer's disease: Structural brain biomarkers

Marizzoni, M., Ferrari, C., Jovicich, J., Albani, D., Babiloni, C., Cavaliere, L., Didic, M., Forloni, G., Galluzzi, S., Hoffmann, K. T., Molinuevo, J. L., Nobili, F., Parnetti, L., Payoux, P., Ribaldi, F., Rossini, P. M., Schönknecht, P., Salvatore, M., Soricelli, A., Hensch, T. & 7 others, Tsolaki, M., Visser, P. J., Wiltfang, J., Richardson, J. C., Bordet, R., Blin, O. & Frisoni, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 3-14 12 p.

Research output: Contribution to journalArticle

Disease Progression
Alzheimer Disease
Biomarkers
Brain
Sample Size
3 Citations (Scopus)

Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity

Jovicich, J., Babiloni, C., Ferrari, C., Marizzoni, M., Moretti, D. V., Del Percio, C., Lizio, R., Lopez, S., Galluzzi, S., Albani, D., Cavaliere, L., Minati, L., Didic, M., Fiedler, U., Forloni, G., Hensch, T., Molinuevo, J. L., Bartrés Faz, D., Nobili, F., Orlandi, D. & 17 others, Parnetti, L., Farotti, L., Costa, C., Payoux, P., Rossini, P. M., Marra, C., Schönknecht, P., Soricelli, A., Noce, G., Salvatore, M., Tsolaki, M., Visser, P. J., Richardson, J. C., Wiltfang, J., Bordet, R., Blin, O. & Frisoniand, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 15-35 21 p.

Research output: Contribution to journalArticle

Alzheimer Disease
Biomarkers
Magnetic Resonance Imaging
Gyrus Cinguli
Evoked Potentials